I .Conventional PCR can do the job but less efficient. 3 base...

I .Conventional PCR can do the job but less efficient. 3 base technology is unique and I am not sure if there are similar products in market, maybe sequencing can do, but it is more expensive at this stage as a routine test. What my concern is not the competitors but market size for 3 base technology. Despite of the potential billion dollar market for molecular diagnosis, how much of this can be attributed to the area of 3 base technology is less known, because 3 base technology, not like conventional PCR, can only be applied to certain medical conditions. Those conditions are very important, but they are not necessarily seen as often as those that require daily routine tests. The size of this market segment will determine the profitability of products. Over the time sales figure will tell us about this.